ARCHIVES

New Opportunities Still Abound In Immunology Program, Terry and other NCI Executives Say

This article is from The Cancer Letter archive.

Vol. 02 No. 09 | February 27, 1976

Download PDF Visit The Full Archive

Related Articles

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

“Withheld” News Release On QRA Policies Released

November 11, 1983

Interview: “People don’t understand Clinical Trials.

September 5, 1997

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993